SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-037697
Filing Date
2020-08-06
Accepted
2020-08-06 16:00:21
Documents
10
Period of Report
2020-09-15
Effectiveness Date
2020-08-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A onvo-def14a_20200915.htm DEF 14A 1688026
2 GRAPHIC g3ipeeod24hy000002.jpg GRAPHIC 3102
3 GRAPHIC g3ipeeod24hy000004.jpg GRAPHIC 2762
4 GRAPHIC g3ipeeod24hy000008.jpg GRAPHIC 53204
5 GRAPHIC g3ipeeod24hy000005.jpg GRAPHIC 10860
6 GRAPHIC g3ipeeod24hy000007.jpg GRAPHIC 3102
7 GRAPHIC g3ipeeod24hy000009.jpg GRAPHIC 50191
8 GRAPHIC g3ipeeod24hy000003.jpg GRAPHIC 3102
9 GRAPHIC g3ipeeod24hy000001.jpg GRAPHIC 2762
10 GRAPHIC g3ipeeod24hy000006.jpg GRAPHIC 9482
  Complete submission text file 0001564590-20-037697.txt   1881379
Mailing Address 440 STEVENS AVENUE, SUITE 200 SOLANA BEACH CA 92075
Business Address 440 STEVENS AVENUE, SUITE 200 SOLANA BEACH CA 92075 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

IRS No.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-35996 | Film No.: 201081415
SIC: 2836 Biological Products, (No Diagnostic Substances)